CN104001045A - 一种用于治疗犬肺炎的药物及其制备方法 - Google Patents
一种用于治疗犬肺炎的药物及其制备方法 Download PDFInfo
- Publication number
- CN104001045A CN104001045A CN201410199487.0A CN201410199487A CN104001045A CN 104001045 A CN104001045 A CN 104001045A CN 201410199487 A CN201410199487 A CN 201410199487A CN 104001045 A CN104001045 A CN 104001045A
- Authority
- CN
- China
- Prior art keywords
- weight portions
- weight portion
- weight
- radix
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 128
- 206010035664 Pneumonia Diseases 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 229940079593 drug Drugs 0.000 title abstract description 24
- 239000000463 material Substances 0.000 claims abstract description 40
- 239000009636 Huang Qi Substances 0.000 claims abstract description 34
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 claims abstract description 26
- 241000489492 Arisaema Species 0.000 claims abstract description 26
- 210000000941 bile Anatomy 0.000 claims abstract description 26
- 241000628997 Flos Species 0.000 claims description 53
- 210000000582 semen Anatomy 0.000 claims description 32
- 241001465967 Holotrichia diomphalia Species 0.000 claims description 31
- 239000000843 powder Substances 0.000 claims description 27
- 241000756943 Codonopsis Species 0.000 claims description 26
- 241000195493 Cryptophyta Species 0.000 claims description 25
- 241000237636 Pheretima Species 0.000 claims description 25
- 241001106462 Ulmus Species 0.000 claims description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 238000001035 drying Methods 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 8
- 239000012141 concentrate Substances 0.000 claims description 6
- 230000006837 decompression Effects 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000001802 infusion Methods 0.000 claims description 6
- 238000000643 oven drying Methods 0.000 claims description 6
- 238000003825 pressing Methods 0.000 claims description 6
- 238000007598 dipping method Methods 0.000 claims description 3
- 206010011224 Cough Diseases 0.000 abstract description 121
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 44
- 208000026435 phlegm Diseases 0.000 abstract description 44
- 230000000694 effects Effects 0.000 abstract description 34
- 206010061218 Inflammation Diseases 0.000 abstract description 9
- 231100000331 toxic Toxicity 0.000 abstract description 6
- 230000002588 toxic effect Effects 0.000 abstract description 6
- 230000009286 beneficial effect Effects 0.000 abstract description 5
- 230000004054 inflammatory process Effects 0.000 abstract description 5
- 244000144725 Amygdalus communis Species 0.000 abstract description 2
- 235000011437 Amygdalus communis Nutrition 0.000 abstract description 2
- 240000000377 Tussilago farfara Species 0.000 abstract description 2
- 235000004869 Tussilago farfara Nutrition 0.000 abstract description 2
- 235000020224 almond Nutrition 0.000 abstract description 2
- 241001063886 Smilax stans Species 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 241000596154 Belamcanda Species 0.000 abstract 1
- 241000412381 Botrypus virginianus Species 0.000 abstract 1
- 235000002566 Capsicum Nutrition 0.000 abstract 1
- 241000132536 Cirsium Species 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 235000017045 Dioscorea septemloba Nutrition 0.000 abstract 1
- 241000908492 Dioscorea septemloba Species 0.000 abstract 1
- 241000218671 Ephedra Species 0.000 abstract 1
- 244000061508 Eriobotrya japonica Species 0.000 abstract 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 abstract 1
- 244000111503 Euphorbia antiquorum Species 0.000 abstract 1
- 241000935235 Fritillaria meleagris Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 241000234435 Lilium Species 0.000 abstract 1
- 241000612166 Lysimachia Species 0.000 abstract 1
- 241000196239 Nitella Species 0.000 abstract 1
- 244000060260 Panicum repens Species 0.000 abstract 1
- 239000006002 Pepper Substances 0.000 abstract 1
- 235000016761 Piper aduncum Nutrition 0.000 abstract 1
- 235000017804 Piper guineense Nutrition 0.000 abstract 1
- 244000203593 Piper nigrum Species 0.000 abstract 1
- 235000008184 Piper nigrum Nutrition 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 241001206339 Rhus punjabensis Species 0.000 abstract 1
- BNXOUFNLXOGIOT-UHFFFAOYSA-N Sarmentose Natural products CC1OC(O)CC(CO)C1O BNXOUFNLXOGIOT-UHFFFAOYSA-N 0.000 abstract 1
- 241000107360 Vincetoxicum glaucescens Species 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- GOYBREOSJSERKM-VQVTYTSYSA-N sarmentose Chemical compound O=CC[C@H](OC)[C@@H](O)[C@@H](C)O GOYBREOSJSERKM-VQVTYTSYSA-N 0.000 abstract 1
- 229940126673 western medicines Drugs 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 description 80
- 210000004369 blood Anatomy 0.000 description 50
- 239000008280 blood Substances 0.000 description 47
- 230000036407 pain Effects 0.000 description 45
- 208000002193 Pain Diseases 0.000 description 43
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 32
- 241000282472 Canis lupus familiaris Species 0.000 description 29
- 230000001717 pathogenic effect Effects 0.000 description 29
- 201000010099 disease Diseases 0.000 description 28
- 210000004185 liver Anatomy 0.000 description 24
- 210000000214 mouth Anatomy 0.000 description 24
- 239000000796 flavoring agent Substances 0.000 description 23
- 235000019634 flavors Nutrition 0.000 description 23
- 231100000614 poison Toxicity 0.000 description 22
- 244000052769 pathogen Species 0.000 description 20
- 210000002784 stomach Anatomy 0.000 description 20
- 241000411851 herbal medicine Species 0.000 description 19
- 230000007812 deficiency Effects 0.000 description 17
- 239000002398 materia medica Substances 0.000 description 17
- 210000000952 spleen Anatomy 0.000 description 17
- 208000000059 Dyspnea Diseases 0.000 description 16
- 206010013975 Dyspnoeas Diseases 0.000 description 16
- 230000008961 swelling Effects 0.000 description 16
- 206010042674 Swelling Diseases 0.000 description 14
- 208000006673 asthma Diseases 0.000 description 14
- 208000001848 dysentery Diseases 0.000 description 14
- 206010007247 Carbuncle Diseases 0.000 description 13
- 206010068319 Oropharyngeal pain Diseases 0.000 description 13
- 201000007100 Pharyngitis Diseases 0.000 description 13
- 210000001015 abdomen Anatomy 0.000 description 13
- 235000009508 confectionery Nutrition 0.000 description 13
- 230000001737 promoting effect Effects 0.000 description 13
- 208000027418 Wounds and injury Diseases 0.000 description 12
- 206010047700 Vomiting Diseases 0.000 description 11
- 239000003172 expectorant agent Substances 0.000 description 11
- 230000003419 expectorant effect Effects 0.000 description 11
- 210000002216 heart Anatomy 0.000 description 11
- 210000003800 pharynx Anatomy 0.000 description 11
- 208000024891 symptom Diseases 0.000 description 11
- 208000011580 syndromic disease Diseases 0.000 description 11
- 206010012735 Diarrhoea Diseases 0.000 description 10
- 208000033809 Suppuration Diseases 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 241000475481 Nebula Species 0.000 description 9
- 206010040943 Skin Ulcer Diseases 0.000 description 9
- 208000013116 chronic cough Diseases 0.000 description 9
- 235000005911 diet Nutrition 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 231100000019 skin ulcer Toxicity 0.000 description 9
- 230000001225 therapeutic effect Effects 0.000 description 9
- 238000002560 therapeutic procedure Methods 0.000 description 9
- 230000008673 vomiting Effects 0.000 description 9
- 210000000988 bone and bone Anatomy 0.000 description 8
- 210000000038 chest Anatomy 0.000 description 8
- 239000002574 poison Substances 0.000 description 8
- 210000001835 viscera Anatomy 0.000 description 8
- 208000008454 Hyperhidrosis Diseases 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 7
- 206010030113 Oedema Diseases 0.000 description 7
- 208000004880 Polyuria Diseases 0.000 description 7
- 230000000954 anitussive effect Effects 0.000 description 7
- 229940124584 antitussives Drugs 0.000 description 7
- 206010006451 bronchitis Diseases 0.000 description 7
- 230000035619 diuresis Effects 0.000 description 7
- 208000001780 epistaxis Diseases 0.000 description 7
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 7
- 231100000252 nontoxic Toxicity 0.000 description 7
- 230000003000 nontoxic effect Effects 0.000 description 7
- 244000045947 parasite Species 0.000 description 7
- 230000007096 poisonous effect Effects 0.000 description 7
- 239000003440 toxic substance Substances 0.000 description 7
- 206010000087 Abdominal pain upper Diseases 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- 208000010201 Exanthema Diseases 0.000 description 6
- 241000282326 Felis catus Species 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 230000002411 adverse Effects 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 230000000378 dietary effect Effects 0.000 description 6
- 201000005884 exanthem Diseases 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 230000002147 killing effect Effects 0.000 description 6
- 201000003453 lung abscess Diseases 0.000 description 6
- 230000003211 malignant effect Effects 0.000 description 6
- 206010037844 rash Diseases 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 206010061245 Internal injury Diseases 0.000 description 5
- 206010023126 Jaundice Diseases 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 210000000621 bronchi Anatomy 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 208000013219 diaphoresis Diseases 0.000 description 5
- 238000005469 granulation Methods 0.000 description 5
- 230000003179 granulation Effects 0.000 description 5
- 210000003026 hypopharynx Anatomy 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 201000004792 malaria Diseases 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 210000001331 nose Anatomy 0.000 description 5
- 230000003405 preventing effect Effects 0.000 description 5
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 5
- 239000013589 supplement Substances 0.000 description 5
- 235000019640 taste Nutrition 0.000 description 5
- 239000003053 toxin Substances 0.000 description 5
- 231100000765 toxin Toxicity 0.000 description 5
- 230000008736 traumatic injury Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 206010063409 Acarodermatitis Diseases 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 4
- 201000004813 Bronchopneumonia Diseases 0.000 description 4
- 206010017553 Furuncle Diseases 0.000 description 4
- 208000000616 Hemoptysis Diseases 0.000 description 4
- 208000004680 Rectal Fistula Diseases 0.000 description 4
- 241000447727 Scabies Species 0.000 description 4
- 206010002156 anal fistula Diseases 0.000 description 4
- 230000001458 anti-acid effect Effects 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 230000000994 depressogenic effect Effects 0.000 description 4
- 238000002651 drug therapy Methods 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 230000002685 pulmonary effect Effects 0.000 description 4
- 230000029058 respiratory gaseous exchange Effects 0.000 description 4
- 208000005687 scabies Diseases 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 231100000820 toxicity test Toxicity 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 3
- 206010008190 Cerebrovascular accident Diseases 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 206010021118 Hypotonia Diseases 0.000 description 3
- 208000015817 Infant Nutrition disease Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 240000005373 Panax quinquefolius Species 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 241000517307 Pediculus humanus Species 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 241000193998 Streptococcus pneumoniae Species 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 206010043376 Tetanus Diseases 0.000 description 3
- 208000002474 Tinea Diseases 0.000 description 3
- 241000130764 Tinea Species 0.000 description 3
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 230000036592 analgesia Effects 0.000 description 3
- 229940069428 antacid Drugs 0.000 description 3
- 239000003159 antacid agent Substances 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 238000002555 auscultation Methods 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 235000013351 cheese Nutrition 0.000 description 3
- 239000000812 cholinergic antagonist Substances 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000003628 erosive effect Effects 0.000 description 3
- 208000017561 flaccidity Diseases 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 208000035861 hematochezia Diseases 0.000 description 3
- 208000014617 hemorrhoid Diseases 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 235000012907 honey Nutrition 0.000 description 3
- 210000000867 larynx Anatomy 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 210000003097 mucus Anatomy 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001047 pyretic effect Effects 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 201000009890 sinusitis Diseases 0.000 description 3
- 230000002048 spasmolytic effect Effects 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 208000019206 urinary tract infection Diseases 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 239000011800 void material Substances 0.000 description 3
- 210000003905 vulva Anatomy 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 2
- 235000017491 Bambusa tulda Nutrition 0.000 description 2
- YWJXCIXBAKGUKZ-HJJNZUOJSA-N Bergenin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@H]2C3=C(O)C(OC)=C(O)C=C3C(=O)O[C@@H]21 YWJXCIXBAKGUKZ-HJJNZUOJSA-N 0.000 description 2
- XULPLJSODQQHPH-UHFFFAOYSA-N Bergenin Natural products OCC1OC2C(OC(=O)c3cc(O)c(CO)c(O)c23)C(O)C1O XULPLJSODQQHPH-UHFFFAOYSA-N 0.000 description 2
- 208000010392 Bone Fractures Diseases 0.000 description 2
- 240000004528 Catalpa ovata Species 0.000 description 2
- 235000010005 Catalpa ovata Nutrition 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 206010010741 Conjunctivitis Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 206010064503 Excessive skin Diseases 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 206010016807 Fluid retention Diseases 0.000 description 2
- 206010018286 Gingival pain Diseases 0.000 description 2
- 206010018291 Gingival swelling Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 201000005569 Gout Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 208000031361 Hiccup Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- OVHUAFPHYGFWPY-UHFFFAOYSA-N Imperialin Natural products CC1CN2CC3C(CCC4C3CC5C4CC(=O)C6CC(O)CCC56C)CC2C(C)(O)C1 OVHUAFPHYGFWPY-UHFFFAOYSA-N 0.000 description 2
- IQDIERHFZVCNRZ-YUYPDVIUSA-N Imperialine Chemical compound C([C@@H]1C(=O)C[C@H]2[C@@H]3CC[C@@H]4[C@]5(C)O)[C@@H](O)CC[C@]1(C)[C@H]2C[C@H]3[C@@H]4CN1[C@H]5CC[C@H](C)C1 IQDIERHFZVCNRZ-YUYPDVIUSA-N 0.000 description 2
- 206010049949 Intercostal neuralgia Diseases 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010023644 Lacrimation increased Diseases 0.000 description 2
- 208000019693 Lung disease Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010033425 Pain in extremity Diseases 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 201000005702 Pertussis Diseases 0.000 description 2
- 244000082204 Phyllostachys viridis Species 0.000 description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 208000001203 Smallpox Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 206010044314 Tracheobronchitis Diseases 0.000 description 2
- 241000870995 Variola Species 0.000 description 2
- IUKLSMSEHKDIIP-BZMYINFQSA-N Verticine Chemical compound C([C@@H]1[C@@H](O)C[C@H]2[C@@H]3CC[C@@H]4[C@]5(C)O)[C@@H](O)CC[C@]1(C)[C@H]2C[C@H]3[C@@H]4CN1[C@H]5CC[C@H](C)C1 IUKLSMSEHKDIIP-BZMYINFQSA-N 0.000 description 2
- 208000000260 Warts Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000000767 anti-ulcer Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 239000011425 bamboo Substances 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000002612 cardiopulmonary effect Effects 0.000 description 2
- 210000003756 cervix mucus Anatomy 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 210000000795 conjunctiva Anatomy 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- 231100000895 deafness Toxicity 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 206010014881 enterobiasis Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000016354 hearing loss disease Diseases 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 2
- 229940029339 inulin Drugs 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 230000004317 lacrimation Effects 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 201000008383 nephritis Diseases 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 238000009527 percussion Methods 0.000 description 2
- IUKLSMSEHKDIIP-UHFFFAOYSA-N petine Natural products CC1(O)C2CCC3C4CC(O)C5CC(O)CCC5(C)C4CC3C2CN2C1CCC(C)C2 IUKLSMSEHKDIIP-UHFFFAOYSA-N 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 235000021395 porridge Nutrition 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 208000010540 rapid respiration Diseases 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 201000003068 rheumatic fever Diseases 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 230000001932 seasonal effect Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 201000010153 skin papilloma Diseases 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 210000005090 tracheal smooth muscle Anatomy 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- PVNIQBQSYATKKL-UHFFFAOYSA-N tripalmitin Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 description 2
- 206010046901 vaginal discharge Diseases 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- AOFUBOWZWQFQJU-SNOJBQEQSA-N (2r,3s,4s,5r)-2,5-bis(hydroxymethyl)oxolane-2,3,4-triol;(2s,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O AOFUBOWZWQFQJU-SNOJBQEQSA-N 0.000 description 1
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- ZESRJSPZRDMNHY-YFWFAHHUSA-N 11-deoxycorticosterone Chemical class O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 ZESRJSPZRDMNHY-YFWFAHHUSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 241001225321 Aspergillus fumigatus Species 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 241000588807 Bordetella Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000006339 Caliciviridae Infections Diseases 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000253350 Capillaria Species 0.000 description 1
- 241000131329 Carabidae Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 241000410367 Clerodendrum thomsoniae Species 0.000 description 1
- 241000223205 Coccidioides immitis Species 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010011376 Crepitations Diseases 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 201000007336 Cryptococcosis Diseases 0.000 description 1
- 241000221204 Cryptococcus neoformans Species 0.000 description 1
- 206010011703 Cyanosis Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012374 Depressed mood Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 208000000655 Distemper Diseases 0.000 description 1
- 101100117236 Drosophila melanogaster speck gene Proteins 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 208000002021 Enophthalmos Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241001248531 Euchloe <genus> Species 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 241000714201 Feline calicivirus Species 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010067715 Gastrointestinal sounds abnormal Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 244000153234 Hibiscus abelmoschus Species 0.000 description 1
- 201000002563 Histoplasmosis Diseases 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000004852 Lung Injury Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000973495 Odax pullus Species 0.000 description 1
- 208000007027 Oral Candidiasis Diseases 0.000 description 1
- 241000702244 Orthoreovirus Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000606856 Pasteurella multocida Species 0.000 description 1
- 206010067781 Pharyngeal abscess Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241000233805 Phoenix Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010065873 Pulmonary fistula Diseases 0.000 description 1
- 206010037742 Rabies Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010062104 Renal mass Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 208000003801 Retropharyngeal Abscess Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 241001473780 Sideroxylon lanuginosum Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 206010040849 Skin fissures Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 244000046101 Sophora japonica Species 0.000 description 1
- 235000010586 Sophora japonica Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 241000223996 Toxoplasma Species 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 206010069363 Traumatic lung injury Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 241000218989 Trichosanthes Species 0.000 description 1
- 241000287411 Turdidae Species 0.000 description 1
- 206010061577 Ulcer haemorrhage Diseases 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010046793 Uterine inflammation Diseases 0.000 description 1
- 240000001519 Verbena officinalis Species 0.000 description 1
- 235000018718 Verbena officinalis Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 208000012873 acute gastroenteritis Diseases 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229940089837 amygdalin Drugs 0.000 description 1
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 229940075522 antidotes Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 229940091771 aspergillus fumigatus Drugs 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 201000009267 bronchiectasis Diseases 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 208000014058 canine distemper Diseases 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 208000003796 chancre Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 208000016644 chronic atrophic gastritis Diseases 0.000 description 1
- 208000021735 chronic enteritis Diseases 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 201000003486 coccidioidomycosis Diseases 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 235000021270 cold food Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 235000013409 condiments Nutrition 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- XCDQFROEGGNAER-PFOIMGGJSA-N epi-Friedelanol Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3CC[C@H](O)[C@@H]1C XCDQFROEGGNAER-PFOIMGGJSA-N 0.000 description 1
- FWTBRZMBHIYQSW-UHFFFAOYSA-N epifriedelanol Natural products CC1C(O)C(O)CC2C1(C)CCC3C2(C)CCC4(C)C5CC(C)(C)CCC5(C)C(O)CC34C FWTBRZMBHIYQSW-UHFFFAOYSA-N 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 229940023064 escherichia coli Drugs 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000003664 filaricide agent Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 210000002175 goblet cell Anatomy 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 208000005562 infectious bovine rhinotracheitis Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000003801 laryngeal nerve Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 231100000515 lung injury Toxicity 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 229940051027 pasteurella multocida Drugs 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 206010037833 rales Diseases 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 208000030133 remittent fever Diseases 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 208000008203 tachypnea Diseases 0.000 description 1
- 206010043089 tachypnoea Diseases 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 229960001947 tripalmitin Drugs 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于治疗犬肺炎的药物及其制备方法,其中,药物包括以下原料药材:党参、蕨萁、黄芪、火殃簕、百合、蛴螬、桔梗、匐地龙、薤白、款冬花、红麸杨、鞘菝葜、浙贝母、水茴香藻、杏仁、假蒟果穗、枇杷叶、白及、海螵蛸、麻黄、甘草、蕤仁、紫菀、白前、绵萆薢、鞘菝葜、矮地茶、胆南星、金沸草、射干、芜荑、牛蒡子、绒背蓟、山豆根和铺地黍。本发明的有益效果是:本发明的药物治疗犬肺炎是通过抗菌消炎、祛痰止咳,可起到效率高,疗效确切,降低死亡率,治愈率高,无毒副作用,相对于西药在治疗效果上,具有治愈时间短、疗程短、疗效好,安全性高、针对性强等特点。
Description
技术领域
本发明涉及中药制剂技术领域,特别涉及一种用于治疗犬肺炎的药物及其制备方法。
背景技术
犬肺炎是指肺实质的炎症,临床上以体温升高、呼吸困难(气喘),胸部叩诊有散在性或广泛性浊音区,胸部听诊有干湿罗音等,X线摄片有特殊表现为特征。
引起本病的病因非常复杂,基本包括以下几个方面:
1.从内科普通病角度,肺炎病因与气管支气管炎基本相同,通常是支气管炎症蔓延的结果,临床多见支气管肺炎。
2.从犬猫肺炎病例中最常分离到金黄色葡萄球菌、溶血性链球菌、肺炎球菌、大肠杆菌、多杀性巴氏杆菌、支气管博代氏杆菌、克雷伯氏杆菌、绿脓杆菌等。
3.从临床实际情况来看,肺炎症状似乎更多见于一些病毒性传染病的过程中。如犬瘟热、犬传染性气管支气管炎、犬呼肠孤病毒感染、猫传染性鼻气管炎、猫杯状病毒感染等,如未得到及时正确的治疗,将发生上述细菌继发性感染,从而表现出典型的支气管肺炎或严重的肺炎症状。此外,某些霉菌感染,如组织胞浆菌病、隐球菌病、球孢子菌病、猫烟曲霉菌病大多表现肺炎症状。
4.某些寄生虫侵袭:如犬猫感染肺毛细线虫、犬类丝虫、猫圆线虫、弓形虫、蛔虫、钩虫等,其幼虫在体内移行也可引起肺组织损伤或支气管肺炎症状。
5.某些化脓性疾病:如动物患急性子宫炎,乳房炎时,其病原可经血液途径侵入肺组织而致病。
由于本病常是急性支气管炎蔓延或进一步发展的结果,所以临床以支气管和肺实质的炎症为特征,临床常说的肺炎多为支气管肺炎。所以病初常有急性支气管炎症状,如明显的咳嗽和流水样或黏液性鼻液。发展到肺泡后全身症状比较严重,其特征性表现是呼吸困难,腹式呼吸明显,精神极为沉郁,食欲废绝。检查体温显著升高,可视黏膜潮红或轻度发绀,听诊肺部局部肺泡音减弱或消失,叩诊肺部出现浊音区,x线检查可见肺叶多部位呈现不规则的阴影。
中兽医认为,犬肺炎属于咳嗽范畴。咳嗽既是独立性的病证,又是肺系多种病证的一个症状。本节是讨论以咳嗽为主要临床表现的一类病证。西医学的上呼吸道感染、支气管炎、支气管扩张、肺炎等以咳嗽为主症者可参考本病证进行辨证论治,其他疾病兼见咳嗽者,可与本病证联系互参。咳嗽分外感咳嗽与内伤咳嗽,外感咳嗽病因为外感六淫之邪;内伤咳嗽病因为饮食、情志等内伤因素致脏腑功能失调,内生病邪。外感咳嗽与内伤咳嗽,均是病邪引起肺气不清失于宣肃,迫气上逆而作咳。
肺主气,咳嗽的基本病机是内外邪气干肺,肺气不清,肺失宣肃,肺气上逆迫于气道而为咳。《医学心悟·咳嗽》指出:“肺体属金,譬若钟然,钟非叩不鸣,风寒暑湿燥火六淫之邪,自外击之则鸣,劳欲情志,饮食炙赙之火自内攻之则亦鸣。”提示咳嗽是肺脏为了祛邪外达所产生的一种病理反应。
《景岳全书·咳嗽》说:“咳证虽多,无非肺病。;这是因为肺主气,其位最高,为五脏之华盖,肺又开窍于鼻,外合皮毛,故肺最易受外感、内伤之邪,而肺又为娇脏,不耐邪侵,邪侵则肺气不清,失于肃降,迫气上逆而作咳。外感咳嗽与内伤咳嗽可相互影响为病,病久则邪实转为正虚。外感咳嗽如迁延失治,邪伤肺气,更易反复感邪,而致咳嗽屡作,转为内伤咳嗽;肺脏有病,卫外不固,易受外邪引发或加重,特别在气候变化时尤为明显。久则从实转虚,肺脏虚弱,阴伤气耗。由此可知,咳嗽虽有外感、内伤之分,但有时两者又可互为因果。辨证候虚实外感咳嗽以风寒、风热、风燥为主,均属实,而内伤咳嗽中的痰湿、痰热、肝火多为邪实正虚,阴津亏耗咳嗽则属虚,或虚中夹实。另外,咳声响亮者多实,咳声低怯者多虚;脉有力者属实,脉无力者属虚。
中医药,不仅具有西药的优势,并且针对犬肺炎因炎症由支气管向肺泡蔓延,肺泡充血、渗出严重,病犬呼吸困难明显,所以对肺炎病犬的抗菌消炎、祛痰止咳和解热用药治疗能除抗菌消炎、祛痰止咳外,还能减少支气管、肺泡的炎性渗出,并能促进渗出物吸收治愈率高的同时无污染,治愈后不易复发,成本价低廉。因此,中医药在治疗犬肺炎疾方面,具有十分重要的现实意义。
发明内容
本发明所要解决的技术问题是:提供一种用于治疗犬肺炎的药物及其制备方法,本发明的药物治疗犬肺炎是通过抗菌消炎、祛痰止咳,可起到效率高,疗效确切,降低死亡率,治愈率高,无毒副作用,相对于西药在治疗效果上,具有治愈时间短、疗程短、疗效好,安全性高、针对性强等特点。
为了实现上述发明目的,本发明提供了一种用于治疗犬肺炎的药物,所述药物包括以下原料药材:党参、蕨萁、黄芪、火殃簕、百合、蛴螬、桔梗、匐地龙、薤白、款冬花、红麸杨、鞘菝葜、浙贝母、水茴香藻、杏仁、假蒟果穗、枇杷叶、白及、海螵蛸、麻黄、甘草、蕤仁、紫菀、白前、绵萆薢、鞘菝葜、矮地茶、胆南星、金沸草、射干、芜荑、牛蒡子、绒背蓟、山豆根和铺地黍。
其中,药物中各原料药材的重量份数优选为:党参10-30重量份、蕨萁15-30重量份、黄芪10-30重量份、火殃簕20-35重量份、百合10-30重量份、蛴螬15-35重量份、桔梗15-30重量份、匐地龙10-30重量份、薤白10-30重量份、款冬花20-35重量份、红麸杨10-30重量份、鞘菝葜10-30重量份、浙贝母15-30重量份、水茴香藻15-30重量份、杏仁15-35重量份、假蒟果穗15-30重量份、枇杷叶20-35重量份、白及10-30重量份、海螵蛸15-30重量份、麻黄20-35重量份、甘草10-30重量份、蕤仁15-30重量份、紫菀10-30重量份、白前15-30重量份、绵萆薢10-30重量份、鞘菝葜10-30重量份、矮地茶15-30重量份、胆南星15-30重量份、金沸草10-30重量份、射干10-30重量份、芜荑15-30重量份、牛蒡子10-30重量份、绒背蓟20-35重量份、山豆根15-35重量份和铺地黍10-30重量份。
其中,药物中各原料药材的重量份数还可以优选为:党参15-30重量份、蕨萁15-25重量份、黄芪10-25重量份、火殃簕20-30重量份、百合15-30重量份、蛴螬15-30重量份、桔梗15-25重量份、匐地龙15-30重量份、薤白15-30重量份、款冬花25-35重量份、红麸杨15-30重量份、鞘菝葜15-30重量份、浙贝母20-30重量份、水茴香藻15-25重量份、杏仁15-30重量份、假蒟果穗20-30重量份、枇杷叶20-30重量份、白及15-30重量份、海螵蛸15-25重量份、麻黄20-30重量份、甘草15-30重量份、蕤仁15-25重量份、紫菀15-30重量份、白前20-30重量份、绵萆薢15-30重量份、鞘菝葜15-30重量份、矮地茶20-30重量份、胆南星20-30重量份、金沸草15-30重量份、射干15-30重量份、芜荑20-30重量份、牛蒡子15-30重量份、绒背蓟20-30重量份、山豆根15-30重量份和铺地黍15-30重量份。
其中,药物中各原料药材的重量份数又可以优选为:党参17-30重量份、蕨萁15-20重量份、黄芪15-25重量份、火殃簕22-30重量份、百合17-30重量份、蛴螬15-25重量份、桔梗17-25重量份、匐地龙18-25重量份、薤白15-25重量份、款冬花25-30重量份、红麸杨18-25重量份、鞘菝葜17-25重量份、浙贝母25-30重量份、水茴香藻19-25重量份、杏仁16-30重量份、假蒟果穗22-30重量份、枇杷叶22-30重量份、白及17-30重量份、海螵蛸18-25重量份、麻黄22-30重量份、甘草18-30重量份、蕤仁18-25重量份、紫菀19-30重量份、白前22-30重量份、绵萆薢17-30重量份、鞘菝葜18-30重量份、矮地茶22-30重量份、胆南星22-30重量份、金沸草16-30重量份、射干17-30重量份、芜荑22-30重量份、牛蒡子18-30重量份、绒背蓟22-30重量份、山豆根18-30重量份和铺地黍17-25重量份。
其中,药物中各原料药材的重量份数又可以优选为:党参17重量份、蕨萁15重量份、黄芪15重量份、火殃簕22重量份、百合17重量份、蛴螬15重量份、桔梗25重量份、匐地龙20重量份、薤白19重量份、款冬花25重量份、红麸杨22重量份、鞘菝葜25重量份、浙贝母27重量份、水茴香藻25重量份、杏仁18重量份、假蒟果穗25重量份、枇杷叶28重量份、白及18重量份、海螵蛸20重量份、麻黄25重量份、甘草22重量份、蕤仁20重量份、紫菀25重量份、白前25重量份、绵萆薢25重量份、鞘菝葜20重量份、矮地茶26重量份、胆南星25重量份、金沸草22重量份、射干19重量份、芜荑27重量份、牛蒡子28重量份、绒背蓟25重量份、山豆根27重量份和铺地黍22重量份。
其中,药物中各原料药材的重量份数又可以优选为:党参20重量份、蕨萁19重量份、黄芪20重量份、火殃簕25重量份、百合18重量份、蛴螬22重量份、桔梗20重量份、匐地龙20重量份、薤白19重量份、款冬花25重量份、红麸杨20重量份、鞘菝葜22重量份、浙贝母28重量份、水茴香藻20重量份、杏仁18重量份、假蒟果穗25重量份、枇杷叶27重量份、白及19重量份、海螵蛸22重量份、麻黄25重量份、甘草25重量份、蕤仁20重量份、紫菀20重量份、白前27重量份、绵萆薢18重量份、鞘菝葜25重量份、矮地茶27重量份、胆南星25重量份、金沸草18重量份、射干25重量份、芜荑22重量份、牛蒡子20重量份、绒背蓟25重量份、山豆根20重量份和铺地黍20重量份。
其中,药物中各原料药材的重量份数又可以优选为:党参26重量份、蕨萁18重量份、黄芪22重量份、火殃簕25重量份、百合19重量份、蛴螬17重量份、桔梗20重量份、匐地龙20重量份、薤白18重量份、款冬花27重量份、红麸杨20重量份、鞘菝葜18重量份、浙贝母28重量份、水茴香藻22重量份、杏仁25重量份、假蒟果穗25重量份、枇杷叶28重量份、白及27重量份、海螵蛸20重量份、麻黄26重量份、甘草22重量份、蕤仁20重量份、紫菀25重量份、白前25重量份、绵萆薢20重量份、鞘菝葜20重量份、矮地茶25重量份、胆南星28重量份、金沸草19重量份、射干20重量份、芜荑25重量份、牛蒡子20重量份、绒背蓟25重量份、山豆根27重量份和铺地黍19重量份。
为解决上述技术问题,本发明提供一种用于治疗犬肺炎的药物的制备方法,所述制备方法包括以下步骤:将所有原料药材投入粉碎机中粉碎成细粉,放入耐酸碱浸渍锅,将相对于细粉质量的3-5倍的醇浓度为80%-90%的乙醇倒入锅中,在常温常压下,浸渍20-30天,随后将浸渍好的液体及药渣压榨过滤,滤液减压浓缩得膏状物,放入烘箱烘干,烘箱干燥的温度为110-115℃,干燥时间10-20分钟,烘干后研磨成150-250目细粉,使其细粉量达到总料的95%以上,得所述药物。
本发明实施例提供的技术方案带来的有益效果是:本发明的药物治疗犬肺炎是通过抗菌消炎、祛痰止咳,可起到效率高,疗效确切,降低死亡率,治愈率高,无毒副作用,相对于西药在治疗效果上,具有治愈时间短、疗程短、疗效好,安全性高、针对性强等特点。
具体实施方式
中兽医认为,治疗犬肺炎应分清邪正虚实。外感咳嗽,为邪气壅肺,多为实证,故以祛邪利肺为治疗原则,根据邪气风寒、风热、风燥的不同,应分别采用疏风、散寒、清热、润燥治疗。内伤咳嗽,多属邪实正虚,故以祛邪扶正,标本兼顾为治疗原则,根据病邪为“痰”与“火”,祛邪分别采用砝痰、清火为治,正虚则养阴或益气为宜,又应分清虚实主次处理。除直接治肺外,还应从整体出发注意治脾、治肝、治肾等。外感咳嗽一般均忌敛涩留邪,当因势利导,俟肺气宣畅则咳嗽自止;内伤咳嗽应防宣散伤正,注意调理脏腑,顾护正气。
因此本发明提供一种用于治疗犬肺炎的药物,所述药物包括以下原料药材:党参、蕨萁、黄芪、火殃簕、百合、蛴螬、桔梗、匐地龙、薤白、款冬花、红麸杨、鞘菝葜、浙贝母、水茴香藻、杏仁、假蒟果穗、枇杷叶、白及、海螵蛸、麻黄、甘草、蕤仁、紫菀、白前、绵萆薢、鞘菝葜、矮地茶、胆南星、金沸草、射干、芜荑、牛蒡子、绒背蓟、山豆根和铺地黍。
所述药物中各组分药理如下:
党参:性平,味甘、微酸;归脾、肺经。补中益气,健脾益肺。用于脾肺虚弱,气短心悸,食少便溏,虚喘咳嗽,内热消渴。该品为临床常用的补气药,功能补脾益肺,效近人参而为较弱,适用于各种气虚不足者。所含皂苷、菊糖、微量生物碱、淀粉等对人体多脏器有不同程度的强壮作用,能提高人体的适应性。有抗溃疡,能增加肠张力、调节胃运动,在调理肠胃制剂中重用党参的肠胃调神剂对慢性腹泻,溃疡性结肠炎,胃窦炎,慢性萎缩性胃炎等颇有效验。
黄芪:为植物和中药材的统称。植物黄芪产于内蒙古、山西、甘肃、黑龙江等地,为国家三级保护植物。中药材黄芪为豆科草本植物蒙古黄芪、膜荚黄芪的根,具有补气固表、利水退肿、托毒排脓、生肌等功效。黄芪的药用迄今已有2000多年的历史,其有增强机体免疫功能、保肝、利尿、抗衰老、抗应激、降压和较广泛的抗菌作用。但表实邪盛,气滞湿阻,食积停滞,痈疽初起或溃后热毒尚盛等实证,以及阴虚阳亢者,均须禁服。黄芪味甘,性微温,归肝、脾、肺、肾经。有益气固表、敛汗固脱、托疮生肌、利水消肿之功效。在中医五行理论中,春季对应的是肝脏,因此,调养肝气对于春季的养生至关重要。黄芪作为补气佳品,在春季生发的季节能够起到一定的补气作用。黄芪熬粥汤,具有益血补气之功效。
百合:除含有蛋白质21.29%、脂肪12.43%、还原糖11.47%、淀粉1.61%,及钙、磷、铁、每百克含1.443毫克维生素B、21.2毫克维生素C等营养素外,还含有一些特殊的营养成分,如秋水仙碱等多种生物碱。这些成分综合作用于人体,不仅具有良好的营养滋补之功,而且还对秋季气候干燥而引起的多种季节性疾病有一定的防治作用。中医上讲鲜百合具有养心安神,润肺止咳的功效,对病后虚弱的人非常有益。
桔梗:味苦,辛,性平。归肺经。具有宣肺、祛痰、利咽、排脓、利五脏、补气血、补五劳、养气的功效。主治咳嗽痰多、咽喉肿痛、肺痈吐脓、胸满胁痛、痢疾腹痛、口舌生疮、目赤肿痛、小便癃闭。用于咳嗽痰多,胸闷不畅,咽痛,音哑,肺痈吐脓,疮疡脓成不溃。《本经》曰:“主胸胁痛如刀刺,腹满,肠鸣幽幽,惊恐悸气”。 《日华子本草》曰:“下一切气,止霍乱转筋,心腹胀痛,补五劳,养气,除邪辟温,补虚消痰,破症瘕,养血排脓,补内漏及喉痹”。现代药理研究表明,桔梗具有祛痰与镇咳作用;降血糖作用;抑制胃液分泌和抗溃疡作用;抗炎作用;镇静、镇痛和解热作用。
款冬花:味辛、性温;归肺经。《日华子本草》:“润心肺,益五脏,除烦,补劳劣,消痰止咳,肺瘘吐血,心虚惊悸,洗肝明目及中风。”《本草乘雅半偈》:“款冬花用治咳逆上气、善喘,喉痹,因肾苦燥及形寒饮冷,秋伤于湿者始宜。或火热刑金,或肺气焦满,恐益消烁毁伤矣。”化痰止咳。有镇咳下气,润肺祛痰的功能。用于咳嗽,气喘,肺痿,咳吐痰血等症。花含款冬二醇等甾醇类、芸香甙、金丝桃甙、三萜皂甙、鞣质、蜡、挥发油和蒲公英黄质。叶含苦味甙2.63%、没食子酸 、弹性橡胶样物质、糊精、粘液、菊糖、植物甾醇、硬脂酸及棕榈酸甘油酯、酒石酸、苹果酸、转化糖、胆碱、碳氢化合物和皂甙。
鞘菝葜:性味甘、苦,微温。归肺经。具有润肺止咳;杀虫灭虱的功效。主新久咳嗽;肺痨;百日咳;蛲虫病;体虱;癣疥。可润肺下气止咳,杀虫。用于新久咳嗽,肺痨咳嗽,百日咳;外用于头虱,体虱,蛲虫病,阴部骚痒。蜜鞘菝葜润肺止咳。用于阴虚劳嗽。药理研究表明,鞘菝葜具有镇咳、祛痰作用;抗病原微生物作用;杀虫作用等。《滇南本草》记载其:“润肺,治肺热咳嗽;消痰定喘,止虚痨咳嗽,杀虫”。
浙贝母:味大苦,性寒;入肺、心、胃、肝经。《本草正》:"大治肺痈肺萎,咳喘,吐血,衄血,最降痰气,善开郁结,止疼痛,消胀满,清肝火,明耳目,除时气烦热,黄疸淋闭,便血溺血;解热毒,杀诸虫及疗喉痹,瘰疬,乳痈发背,一切痈疡肿毒,湿热恶疮,痔漏,金疮出血,火疮疼痛,较之川贝母,清降之功,不啻数倍。"《山东中草药手册》:“清肺化痰,制酸,解毒。”《神农本草经逢原》:“贝母,川者味甘最佳:西者味薄次之,象山者微苦又次之,一种大而苦者仅能解毒。并去心用。凡肺经药皆当去心,不独贝母也。”清热化痰,散结解毒。用治风热咳嗽,肺痈喉痹,瘰疬,疮疡肿毒。镇咳贝母碱与去氢贝母碱有镇咳作用.解痉贝母生物碱具有阿托品样作用,低浓度可使气管平滑肌松弛, 高浓度可使气管平滑肌轻微收缩.对中枢神经系统的作用贝母碱与去氢贝母碱有镇静及镇痛作用.
杏仁:苦,微温;有小毒。《名医别录》:“杏核仁,五月采之。其两仁者杀人,可以毒狗。生晋山川谷。”《神农本草经》:“主咳逆上气雷鸣,喉痹,下气,产乳金疮,寒心奔豚。”《药性论》:“治腹痹不通,发汗,主温病。治心下急满痛,除心腹烦闷,疗肺气咳嗽,上气喘促。入天门冬煎,润心肺。可和酪作汤,益润声气。宿即动冷气。”止咳平喘,润肠通便。《本草经集注》:“得火良。恶黄耆、黄芩、葛根。畏蘘草。”杏仁苦温宣肺,润肠通便、仅适宜于风邪、肠燥等实证之患。凡阴亏、郁火者,则不宜单味药长期内服。如肺结核、支气管炎、慢性肠炎、干咳无痰等症禁忌单味药久服。正确食用杏仁,能够达到生津止渴,润肺定喘,滑肠通便,减少肠道癌的功效。杏仁烹调的方法很多,可以用来做粥、饼、面包等多种类型的食品,还能搭配其他佐料制成美味菜肴。
枇杷叶:苦,微寒;归肺,胃经。《滇南本草》:"止咳嗽,消痰定喘,能断痰丝,化顽痰,散吼喘,止气促。"《本草再新》:"清肺气,降肺火,止咳化痰,止吐血呛血,治痈痿热毒。"清肺止咳,降逆止呕。肺热咳嗽,气逆喘急,胃热呕吐,哕逆。可治疗口干消渴,肺风面疮,粉刺。。枇杷叶味苦性寒,具有降气清肺止咳之功,用治肺热咳嗽,可配黄芩、栝楼皮等药以清肺化痰止咳。其味微辛,兼能疏泄肺气,故风热咳嗽亦可配以前胡、桑叶等以疏风宣肺止咳。枇杷叶入胃经,善清胃热、降胃气而奏止呕哕、治呃逆之效。胃热呕逆还可以单用。本品所含苦杏仁甙在体内水解产生的氢氰酸有止咳作用.水煎剂或乙酸乙酯提取物对白色或金黄色葡萄球菌、肺炎双球菌、福氏痢疾杆菌均有抗菌作用.
白及:苦、甘、涩,微寒;归肺、肝、胃经。收敛止血,消肿生肌。《日华子本草》:"止惊邪、血邪,痢疾,赤眼,症结,发背,瘰疬,肠风,痔瘿,刀箭疮扑损,温热疟疾,血痢,汤火疮,生肌止痛,风痹。"《本草图经》:"治金疮不瘥,痈疽方中多用之。"用于咳血吐血,外伤出血,疮疡肿毒,皮肤皲裂;肺结核咳血,溃疡病出血。白芨富含淀粉、葡萄糖、挥发油、粘液质等,外用涂擦,可消除脸上痤疮般下的痕迹,让肌肤光滑无痕。
麻黄:性味辛、微苦,温。归肺、膀胱经。具有发汗散寒,宣肺平喘,利水消肿的功效。麻黄除了辛温发汗、解表散寒以外,并有明显的宣肺平喘作用。凡是风寒外侵、毛窍束闭而致肺气不得宣通的外感喘咳,都可用麻黄治疗(风寒表实无汗证)。即使是表证已解,但仍喘咳的,还可以继续用麻黄治疗,这时可改用炙麻黄。生麻黄发汗解表的效力大,炙麻黄发汗力小而平喘止咳的效果较好。用麻黄治疗喘咳,最好配上杏仁。麻黄宣通肺气以平喘止咳,杏仁降气化痰以平喘止咳,麻黄性刚烈,杏仁性柔润,二药合用,可以增强平喘止咳的效果,所以临床上有“麻黄以杏仁为臂助”的说法。喘咳的病人,如出现肺热的证候(痰黄稠、喉燥咽干、口鼻气热、遇热则喘咳加重、苔黄、脉数等),则需加入生石膏,或黄芩、知母等,以清肺热而平喘。《本草经疏》:麻黄,轻可去实,故疗伤寒,为解肌第一。专主中风伤寒头痛,温疟,发表出汗,去邪气者,盖以风寒湿之外邪,客于阳分皮毛之间,则腠理闭拒,荣卫气血不能行,故谓之实,此药轻清,故能去其壅实,使邪从表散也;咳逆上气者,风寒郁于手太阴也;寒热者,邪在表也;五脏邪气缓急者,五缓六急也;风胁痛者,风邪客于胁下也,斯皆卫实之病也。卫中风寒之邪既散,则上来诸证自除矣。其日消赤黑斑毒者,若在春夏,非所宜也。破坚积聚,亦非发表所能。洁古云:去荣中寒邪,泄卫中风热,乃确论也。多服令人虚,走散真元之气故也。
甘草:性味甘,平。入脾、胃、肺经。可益气补中;缓急止痛;润肺止咳;泻火解毒;调和诸药。主倦怠食少;肌瘦面黄;心悸气短;腹痛便溏;四肢挛急疼痛;脏躁;咳嗽气喘;咽喉肿痛;痈疮肿痛;小儿胎毒;及药物、食物中毒。用于脾胃虚弱,倦怠乏力,心悸气短,咳嗽痰多,脘腹、四肢挛急疼痛,痈肿疮毒,缓解药物毒性、烈性。《本经》曰:“主五脏六府寒热邪气,坚筋骨,长肌肉,倍力,金疮肿,解毒”。人阴(不)《药性论》曰:“主腹中冷痛,治惊痫,除腹胀满;补益五脏;制诸药毒;养肾气内伤,令痿;主妇人血沥腰痛;虚而多热;加而用之”。 西医药理发现,甘草剂有抗炎和抗变态反映的功能,因此在西医临床上主要作为缓和剂。缓解咳嗽,祛痰,治疗咽痛喉炎;甘草或甘草次酸有去氧皮质酮类作用,对慢性肾上腺皮质功能减退症有良好功效;甘草制剂能促进胃部粘液形成和分泌,延长上皮细胞寿命,有抗炎活性,常用于慢性溃疡和十二指肠溃疡的治疗;甘草的黄酮具有消炎、解痉和抗酸作用;甘草也是人丹的主要原料之一。
紫菀:性温,味苦、辛。《本草经疏》:“紫菀,观其能开喉痹,取恶涎,则辛散之功烈矣,而其性温,肺病咳逆喘嗽,皆阴虚肺热证也,不宜专用及多用,即用亦须与天门冬、鞘菝葜、麦冬、桑白皮苦寒之药参用,则无害。”润肺下气,化痰止咳。主咳嗽,肺虚劳嗽,肺痿肺痈,咳吐脓血,小便不利。用于痰多喘咳,新久咳嗽,劳嗽咳血。用于治疗慢性咳嗽气喘。提取物及分离表无羁萜醇对艾氏腹水癌有一定的抗癌作用。煎剂口服能增加麻醉兔及大鼠呼吸道分泌物而具祛痰作用。其皂素及苯和甲醇提取物均有祛痰作用。《本草经集注》:“款冬为使。恶天雄、瞿麦、雷丸、远志。畏茵陈蒿。”
白前:辛、苦,微温;归肺经。《唐本草》:“白前,叶似柳,或似芫花,苗高尺许,生洲渚沙碛之上。根白,长于细辛,味甘。俗以酒渍服,主上气。不生近道。今用蔓生者,味苦,非真也。”《本经逢原》:“白前,较白薇稍温,较细辛稍平。专搜肺窍中风水,非若白薇之咸寒,专泄肺、胃之燥热,亦不似细辛之辛窜,能治肾、肝之沉寒也。”降气化痰,止咳。咳嗽痰多,气喘。该品性微温而不燥烈,长于祛痰,降肺气以平咳喘。无论属寒属热,外感内伤,新嗽久咳均可用之。咳喘属气虚不归元者,不宜应用。炒白前用文火加热,炒至老黄色,微焦,取出放凉。炒后偏于温肺散寒、化痰止咳,多用于寒痰或痰湿、咳喘。
矮地茶:性平,味辛、微苦;归肺、肝经。《本草纲目拾遗》:“治吐血劳伤,怯症垂危,久嗽成劳。”《植物名实图考》:“治肿毒,血痢,解蛇毒,救中暑。”《上海常用中草药》:“活血止痛,利尿,健胃,止血。治湿热黄疸,肝炎,急性肾炎,膀胱炎,肺结核盗汗、咯血,脱力劳伤,筋骨酸痛,月经不调,副鼻窦炎。”性平偏凉,祛痰止咳平喘作用较明显,咳喘有痰而属热者尤为适宜。又能清利湿热,活血化瘀,也可用治湿热黄疸、水肿,以及经闭痛经,风湿痹痛,跌打损伤等证。矮地茶煎剂及其提出物矮茶素1号对电刺激猫喉上神经所引起的咳嗽及氨水喷雾引起的小鼠咳嗽都有明显的止咳作用。每日吸入二氧化硫产生慢性气管炎的大鼠,内服矮茶素1号有一定的预防及治疗作用,表现为杯状细胞减少,炎细胞浸润、肺气肿及肺萎缩程度减轻。
金沸草:味咸,性温,有小毒。《天宝本草》:“清肺除热,散寒去火。治呕喘咳嗽,吐衄,开窍通淋。”《四川中药志》:“止咳化痰,定喘除饮。治心脾伏饮,胁下胀痛,肺中痰结,唾如胶漆,及风气湿痹。”散风寒,化痰饮,消肿毒,祛风湿。主风寒咳嗽,伏饮痰喘,胁下胀痛,可疮肿毒,风湿疼痛。金沸草煎剂5mg/ml用原代人胚肌皮单层细胞培养法,表明对单纯疱疹病毒(I型)有抑制作用。全草煎剂用平板纸片法,对金黄色葡萄球菌、肺炎链球菌、绿脓杆菌、大肠杆菌有抑制作用。
射干:性味苦,寒。入肺、肝经。具有清热解毒,利咽喉,消痰涎,疗咽闭,消痈毒的功效。现代研究表明,其具有抗病原微生物、抗炎的作用。射干用于感受风热,或痰热壅盛所致的咽喉肿痛等症。射干为治咽喉肿痛常用的药品,能清热毒、消肿痛。
牛蒡子:味辛,苦,性寒;归肺,胃经。可疏散风热;清热解毒透疹;宣肺利咽散肿。主治风热感冒、温病初起;风热或肺热咳嗽、咯痰不畅;咽喉肿痛;斑疹不透;麻疹初期,疹出不畅及风疹瘙痒;疮疡肿毒及痄腮等。生用可润肠通便,热毒咽喉红肿疼痛,兼有热结便秘尤宜。《本草经疏》曰:“恶实,为散风除热解毒之要药。辛能散结,苦能泄热,热结散则脏气清明,故明目而补中。风之所伤,卫气必壅,壅则发热,辛凉解散则表气和,风无所留矣。藏器主风毒肿诸痿;元素主润肺、散结气、利咽膈、去皮肤风、通十二经络者,悉此意耳。故用以治瘾疹、痘疮,尤获奇验”。
山豆根:功能主治:清火解毒,消肿止痛。用于咽喉牙龈肿痛、肺热咳嗽烦渴、黄疸、热结便秘。治喉痈,喉风,喉痹,牙龈肿痛,喘满热咳,黄疸,下痢,痔疾,热肿,秃疮,疥癣,蛇、虫、犬咬伤。①《开宝本草》:“味甘,寒,无毒。”②《梦溪笔谈·药议》:“味极苦。”③ 《本草正》:“味大苦,大寒。”《要药分剂》:“入心、肺、大肠三经。始载于《开宝本草》。《本草图经》云:“生剑南及宜州、果州山谷。今广西亦有,以忠州、万州者为佳苗蔓 如豆,根以此为名叶青,经疼不凋 ,八月采根用。”又曰:广南者如小槐,高尺余。”《本草品汇精要》云:“道地宜州、果州、以忠、万州者佳。”《药物出产辨》云:“产广西南宁、百色等处。”
绒背蓟:性味:微辛,温。主治: 祛风,除湿,止痛。用于风湿性关节炎,四肢麻木。铺地黍:性味:甘,平。主治: 清热平肝,利湿解毒。主治高血压病,鼻窦炎,鼻出血,湿热带下,尿路感染,肋间神经痛,黄疸型肝炎,骨鲠喉。
海螵蛸:性味:咸,微温。①《本经》:"味咸,微温。"②《吴普本草》:"冷。"③《别录》:"无毒。"④《药性论》:"有小毒。"归经:入肝、肾经。①《纲目》:"厥阴血分。"②《雷公炮制药性解》:"入肾经。"③《本草再新》:"入肝、脾、肾三经。主治: 除湿,制酸,止血,敛疮。治胃痛吞酸,吐、衄、呕血,便血,崩漏带下,血枯经闭,腹痛症瘕,虚疟泻痢,阴蚀烂疮。①《本经》:"主女子漏下赤白经汁,血闭,阴蚀肿痛,寒热症瘕,无子。"②《别录》:"惊气入腹,腹痛环脐,阴中寒肿(一作"丈夫阴中肿痛》),又止疮多脓汁不燥。"③《药性论》:"止妇人漏血,主耳聋。"④《唐本草》:"疗人目中翳。"⑤《食疗本草》:"主小儿大人下痢,炙今黄,去皮细研成粉,粥中调服之。"⑥《本草拾遗》:"主妇人血瘕,杀小虫。"⑦《日华子本草》:"疗血崩。"⑧《纲目》:"主女子血枯病,伤肝,唾血下血,治疟消瘿。研末敷小儿疳疮,痘疮臭烂,丈夫阴疮,汤火伤,跌伤出血。烧存性,同鸡子黄涂小儿重舌、鹅口,同蒲黄末敷舌肿血出如泉,同银朱吹鼻治喉痹,同麝香吹耳治聤耳有脓及耳聋。"⑨《要药分剂》:"通经络,去寒湿。"⑩《现代实用中药》:"为制酸药,对胃酸过多、胃溃疡有效。"
火殃簕:性味:苦,寒。有毒。主治:茎、叶:消肿,拔毒,止泻。用于急性胃肠炎,疟疾,跌打肿痛。
蕨萁:性味,苦、涩,凉。主治:清热解毒,消肿散结。用于肺脓疡,眼结膜炎;外用治跌打损伤,蛇咬伤,颈淋巴结结核。
蛴螬:性味: ①《本经》:"味咸,微温。"②《别录》:"微寒,有毒。"归经:《本草汇言》:"入足厥阴肝经。"主治:破血,行瘀,散结,通乳。治折损瘀痛,痛风,破伤风,喉痹,目翳,丹毒,痈疽,痔漏。①《本经》:"主恶血血瘀痹气,破折血在胁下坚满痛,月闭,目中淫肤、青翳白膜。"②《别录》:"疗吐血在胸腹不去及破骨踒折血结,金疮内塞,产后中寒,下乳汁。"③《药性论》:"汁滴目中,去翳障,主血,止痛。"④《本草拾遗》:"主赤白游疹,疹擦破,碎蛴螬取汁涂之。"⑤《日华子本草》:"可敷恶疮。"①《纲目》:蛴螬,"《本事方》治筋急,养血地黄丸中用之,取其治血瘀痹也。陈氏《经验方》云:盛冲母失明,取蛴螬蒸熟食,目即开。与《本经》治目中青翳白膜,《药性论》汁滴目中去翳障之说相合。《婴童百问》治破伤风,又符疗踒折、敷恶疮、金疮内塞、主血、止痛之说也。盖此药能行血分,散结滞,故能治以上诸病。"②《长沙药解》:"蛴螬,能化瘀血,最消症块。《金匮》大黄蟅虫丸用之,治虚劳腹满,内有干血,以其破瘀而化积也。"
匐地龙:性味:微苦,凉。主治:利尿排石,清热解毒,理脾消积。用于尿路结石,胆道结石,黄疸型传染性肝炎,狂犬病,蕈子中毒,小儿疳积,牙龈肿毒,痈肿疔疮。
薤白:性味:辛苦,温。①《木经》:"味辛,温。"②《别录》:"苦,温,无毒。"③《千金·食治》:"味苦辛,温,滑,无毒。"④《医林纂要》:"甘酸辛,温。"归经:①《汤液本草》:"入手阳明经。"②《本草经解》:"入足厥阴肝经、手太阴肺经、手少阴心经。"主治:理气,宽胸,通阳,散结。治胸痹心痛彻背,脘痞不舒,干呕,泻痢后重,疮疖。①《本经》:"主金疮疮败。"②《别录》:"归于骨。除寒热,去水气,温中散结。诸疮中风寒水肿,以涂之。"③《千金·食治》:"能生肌肉,利产妇。骨鲠在咽不下者,食之则去。"④唐本草》:"白者补而美,赤者主金疮及凤。"⑤《食疗本草》:"治妇人赤白带下。"⑥《本草拾遗》:"调中,主久利不瘥,大腹内常恶者,但多煮食之。"⑦《本草图经》:"补虚,解毒。""主脚气;煮与蓐妇饮之,易产。"⑧《本草衍义》:"与蜜同捣,涂汤火伤。"⑨《用药心法》:"治泄痢下重,下焦气滞。"⑩《纲目》:"治少阴病厥逆泄痢,及胸痹刺痛,下气散血,安胎。""温补助阳道。"⑾《本草备要》:"利窍。治肺气喘急。"⑿《本经逢原》:"捣汁生饮,能吐胃中痰食虫积。"⒀《岭南采药录》:"和生盐捣烂敷疮;被铁针伤,留铁锈于肌肉,敷之可以吸出。能发散解表,健胃,开膈。"⒁《南京民间药草》:"打烂外敷,治各种疮疖。另外取野菊花煎水内服。"
红麸杨:主治:①《湖南药物志》:"治痢疾。"②《贵州药植目录》:"涩肠。治痢疾,腹泻。"
水茴香藻:性味,辛;平。归经:肺经。主治:疏风清热;止咳。主风热感冒;咳嗽;烫伤。蛴螬:性味:①《本经》:"味咸,微温。"②《别录》:"微寒,有毒。"归经:《本草汇言》:"入足厥阴肝经。"主治:破血,行瘀,散结,通乳。治折损瘀痛,痛风,破伤风,喉痹,目翳,丹毒,痈疽,痔漏。①《本经》:"主恶血血瘀痹气,破折血在胁下坚满痛,月闭,目中淫肤、青翳白膜。"②《别录》:"疗吐血在胸腹不去及破骨踒折血结,金疮内塞,产后中寒,下乳汁。"③《药性论》:"汁滴目中,去翳障,主血,止痛。"④《本草拾遗》:"主赤白游疹,疹擦破,碎蛴螬取汁涂之。"⑤《日华子本草》:"可敷恶疮。"
假蒟果穗:性味:"微辛,温。"主治: ①广州部队《常用中草药手册》:"温中暖胃,驱风行气。治腹胀腹痛,肠炎腹泻,食欲不振,肾炎水肿,风湿痛。"②《广东中草药》:"化湿消肿,行气通窍,消滞化痰。治水肿,风湿性关节炎,疝气痛,风寒咳嗽。"
蕤仁:性味:甘,寒。①《别录》:"微寒,无毒。"②《医林纂要》:"甘咸,寒。"归经:入肝、心经。①《雷公炮制药性解》:"入心、肝、脾三经。"②《玉楸药解》:"入手太阴肺、足厥阴肝经。"主治:祛风,散热,养肝,明目。治目赤肿痛,昏暗羞明,眦烂多泪,鼻衄。①《本经》:"主心腹邪结气,明目,目赤痛伤泪出。"②《吴普本草》:"补中强志,明耳目。"③《别录》:"目肿眦烂,齆鼻,破心下结痰痞气。"④《药性论》:"治鼻衄。"⑤《本草拾遗》:"生治足睡,熟治不眠。"⑥《本草蒙筌》:"专治眼科,消上下胞风肿烂弦,除左右眦热障胬肉,退火止泪,益水生光。"
绵萆薢:性味:苦,平。归经:归肾、胃经。主治:利湿去浊,祛风通痹。用于淋病白浊,白带过多,湿热疮毒,腰膝痹痛。
鞘菝葜:性味:①《甘肃中草药手册》:"辛咸,温。"②《河南经济植物志》:"味苦,性平,无毒。"主治:祛风除湿,活血顺气,止痛。治风湿疼痛,跌打损伤,外伤出血,鱼骨鲠喉。①《甘肃中草药手册》:"祛风除湿,通络止痛。治风湿腰膝四肢疼痛久不愈,鱼骨鲠喉。"②《河南经济植物志》:"活血止痛。治折伤,创伤。"③《中国经济植物志》:"顺气镇痛。"
胆南星:性味:苦、微辛,凉。归经:归肺、肝、脾经。主治:清热化痰,息风定惊。用于痰热咳嗽,咯痰黄稠,中风痰迷,癫狂惊痫。
芜荑:性味:苦辛,温。①《本经》:"味辛,平。"②《药性论》:"味苦辛。"③《海药本草》:"味辛,温,无毒。"归经:入脾、胃经。①《雷公炮制药性解》:"入肺、脾二经。"②《玉楸药解》:"入厥阴肝经。"③《要药分剂》:"入脾、胃二经。"④《本草再新》:"入心、脾二经。"主治:杀虫,消积。治虫积腹痛。小儿疳泻、冷痢,疥癣,恶疮。①《本经》:"主五内邪气,散皮肤骨节中淫淫温行毒,去三虫,化食。"②《别录》:"逐寸白,散肠中嗢嗢喘息。"③《药性论》:"能主积冷气,心腹症痛,除肌肤节中风淫淫如虫行。"④孟诜:"治热疮,捣和猪脂涂。又和白蜜治湿癣。和沙牛酪疗一切疮。长食治五痔。"⑤《食疗本草》:"散腹中气痛。又和马酪可治癣。又杀中恶虫毒。"⑥《海药本草》:"治冷痢心气,杀虫止痛。又治妇人子宫风虚,孩子疳泻。"⑦《日华子本草》:"治肠风痔漏,恶疮疥癣。"⑧《医林纂要》:"泻肺法风湿,燥脾消寒食,治疸黄,杀虫去蛔。"⑨《中国药植图鉴》:"祛痰利尿。"青骨藤:性味,苦、辛,凉。有小毒。主治:镇痛,止血,清热,利尿。用于跌打损伤,风湿骨痛,胃腹疼痛,支气管炎,尿路感染;外用治外伤出血,疮疖肿毒。
铺地黍:又称硬骨草、田基姜、风台草、竹蒿草头、马鞭节。性味:甘,平。主治:清热平肝,利湿解毒。主治高血压病,鼻窦炎,鼻出血,湿热带下,尿路感染,肋间神经痛,黄疸型肝炎,骨鲠喉。
其中,药物中各原料药材的重量份数优选为:党参10-30重量份、蕨萁15-30重量份、黄芪10-30重量份、火殃簕20-35重量份、百合10-30重量份、蛴螬15-35重量份、桔梗15-30重量份、匐地龙10-30重量份、薤白10-30重量份、款冬花20-35重量份、红麸杨10-30重量份、鞘菝葜10-30重量份、浙贝母15-30重量份、水茴香藻15-30重量份、杏仁15-35重量份、假蒟果穗15-30重量份、枇杷叶20-35重量份、白及10-30重量份、海螵蛸15-30重量份、麻黄20-35重量份、甘草10-30重量份、蕤仁15-30重量份、紫菀10-30重量份、白前15-30重量份、绵萆薢10-30重量份、鞘菝葜10-30重量份、矮地茶15-30重量份、胆南星15-30重量份、金沸草10-30重量份、射干10-30重量份、芜荑15-30重量份、牛蒡子10-30重量份、绒背蓟20-35重量份、山豆根15-35重量份和铺地黍10-30重量份。
其中,药物中各原料药材的重量份数还可以优选为:党参15-30重量份、蕨萁15-25重量份、黄芪10-25重量份、火殃簕20-30重量份、百合15-30重量份、蛴螬15-30重量份、桔梗15-25重量份、匐地龙15-30重量份、薤白15-30重量份、款冬花25-35重量份、红麸杨15-30重量份、鞘菝葜15-30重量份、浙贝母20-30重量份、水茴香藻15-25重量份、杏仁15-30重量份、假蒟果穗20-30重量份、枇杷叶20-30重量份、白及15-30重量份、海螵蛸15-25重量份、麻黄20-30重量份、甘草15-30重量份、蕤仁15-25重量份、紫菀15-30重量份、白前20-30重量份、绵萆薢15-30重量份、鞘菝葜15-30重量份、矮地茶20-30重量份、胆南星20-30重量份、金沸草15-30重量份、射干15-30重量份、芜荑20-30重量份、牛蒡子15-30重量份、绒背蓟20-30重量份、山豆根15-30重量份和铺地黍15-30重量份。
其中,药物中各原料药材的重量份数又可以优选为:党参17-30重量份、蕨萁15-20重量份、黄芪15-25重量份、火殃簕22-30重量份、百合17-30重量份、蛴螬15-25重量份、桔梗17-25重量份、匐地龙18-25重量份、薤白15-25重量份、款冬花25-30重量份、红麸杨18-25重量份、鞘菝葜17-25重量份、浙贝母25-30重量份、水茴香藻19-25重量份、杏仁16-30重量份、假蒟果穗22-30重量份、枇杷叶22-30重量份、白及17-30重量份、海螵蛸18-25重量份、麻黄22-30重量份、甘草18-30重量份、蕤仁18-25重量份、紫菀19-30重量份、白前22-30重量份、绵萆薢17-30重量份、鞘菝葜18-30重量份、矮地茶22-30重量份、胆南星22-30重量份、金沸草16-30重量份、射干17-30重量份、芜荑22-30重量份、牛蒡子18-30重量份、绒背蓟22-30重量份、山豆根18-30重量份和铺地黍17-25重量份。
其中,药物中各原料药材的重量份数又可以优选为:党参17重量份、蕨萁15重量份、黄芪15重量份、火殃簕22重量份、百合17重量份、蛴螬15重量份、桔梗25重量份、匐地龙20重量份、薤白19重量份、款冬花25重量份、红麸杨22重量份、鞘菝葜25重量份、浙贝母27重量份、水茴香藻25重量份、杏仁18重量份、假蒟果穗25重量份、枇杷叶28重量份、白及18重量份、海螵蛸20重量份、麻黄25重量份、甘草22重量份、蕤仁20重量份、紫菀25重量份、白前25重量份、绵萆薢25重量份、鞘菝葜20重量份、矮地茶26重量份、胆南星25重量份、金沸草22重量份、射干19重量份、芜荑27重量份、牛蒡子28重量份、绒背蓟25重量份、山豆根27重量份和铺地黍22重量份。
其中,药物中各原料药材的重量份数又可以优选为:党参20重量份、蕨萁19重量份、黄芪20重量份、火殃簕25重量份、百合18重量份、蛴螬22重量份、桔梗20重量份、匐地龙20重量份、薤白19重量份、款冬花25重量份、红麸杨20重量份、鞘菝葜22重量份、浙贝母28重量份、水茴香藻20重量份、杏仁18重量份、假蒟果穗25重量份、枇杷叶27重量份、白及19重量份、海螵蛸22重量份、麻黄25重量份、甘草25重量份、蕤仁20重量份、紫菀20重量份、白前27重量份、绵萆薢18重量份、鞘菝葜25重量份、矮地茶27重量份、胆南星25重量份、金沸草18重量份、射干25重量份、芜荑22重量份、牛蒡子20重量份、绒背蓟25重量份、山豆根20重量份和铺地黍20重量份。
其中,药物中各原料药材的重量份数又可以优选为:党参26重量份、蕨萁18重量份、黄芪22重量份、火殃簕25重量份、百合19重量份、蛴螬17重量份、桔梗20重量份、匐地龙20重量份、薤白18重量份、款冬花27重量份、红麸杨20重量份、鞘菝葜18重量份、浙贝母28重量份、水茴香藻22重量份、杏仁25重量份、假蒟果穗25重量份、枇杷叶28重量份、白及27重量份、海螵蛸20重量份、麻黄26重量份、甘草22重量份、蕤仁20重量份、紫菀25重量份、白前25重量份、绵萆薢20重量份、鞘菝葜20重量份、矮地茶25重量份、胆南星28重量份、金沸草19重量份、射干20重量份、芜荑25重量份、牛蒡子20重量份、绒背蓟25重量份、山豆根27重量份和铺地黍19重量份。
为解决上述技术问题,本发明提供一种用于治疗犬肺炎的药物的制备方法,所述制备方法包括以下步骤:将所有原料药材投入粉碎机中粉碎成细粉,放入耐酸碱浸渍锅,将相对于细粉质量的3-5倍的醇浓度为80%-90%的乙醇倒入锅中,在常温常压下,浸渍20-30天,随后将浸渍好的液体及药渣压榨过滤,滤液减压浓缩得膏状物,放入烘箱烘干,烘箱干燥的温度为110-115℃,干燥时间10-20分钟,烘干后研磨成150-250目细粉,使其细粉量达到总料的95%以上,得所述药物。
实施例1 药物1
本发明实施例提供了一种用于治疗犬肺炎的药物,由以下重量份数的原料药材制成:党参17重量份、蕨萁15重量份、黄芪15重量份、火殃簕22重量份、百合17重量份、蛴螬15重量份、桔梗25重量份、匐地龙20重量份、薤白19重量份、款冬花25重量份、红麸杨22重量份、鞘菝葜25重量份、浙贝母27重量份、水茴香藻25重量份、杏仁18重量份、假蒟果穗25重量份、枇杷叶28重量份、白及18重量份、海螵蛸20重量份、麻黄25重量份、甘草22重量份、蕤仁20重量份、紫菀25重量份、白前25重量份、绵萆薢25重量份、鞘菝葜20重量份、矮地茶26重量份、胆南星25重量份、金沸草22重量份、射干19重量份、芜荑27重量份、牛蒡子28重量份、绒背蓟25重量份、山豆根27重量份和铺地黍22重量份。
上述药物是通过以下制备方法制得:将所有原料药材投入粉碎机中粉碎成细粉,放入耐酸碱浸渍锅,将相对于细粉质量的3.5倍的醇浓度为85%的乙醇倒入锅中,在常温常压下,浸渍25天,随后将浸渍好的液体及药渣压榨过滤,滤液减压浓缩得膏状物,放入烘箱烘干,烘箱干燥的温度为110℃,干燥时间15分钟,烘干后研磨成180目细粉,使其细粉量达到总料的95%以上,得所述药物。
实施例2 药物2
本发明实施例提供了一种用于治疗犬肺炎的药物,由以下重量份数的原料药材制成:党参20重量份、蕨萁19重量份、黄芪20重量份、火殃簕25重量份、百合18重量份、蛴螬22重量份、桔梗20重量份、匐地龙20重量份、薤白19重量份、款冬花25重量份、红麸杨20重量份、鞘菝葜22重量份、浙贝母28重量份、水茴香藻20重量份、杏仁18重量份、假蒟果穗25重量份、枇杷叶27重量份、白及19重量份、海螵蛸22重量份、麻黄25重量份、甘草25重量份、蕤仁20重量份、紫菀20重量份、白前27重量份、绵萆薢18重量份、鞘菝葜25重量份、矮地茶27重量份、胆南星25重量份、金沸草18重量份、射干25重量份、芜荑22重量份、牛蒡子20重量份、绒背蓟25重量份、山豆根20重量份和铺地黍20重量份。
上述药物是通过以下制备方法制得:将所有原料药材投入粉碎机中粉碎成细粉,放入耐酸碱浸渍锅,将相对于细粉质量的5倍的醇浓度为80%的乙醇倒入锅中,在常温常压下,浸渍20天,随后将浸渍好的液体及药渣压榨过滤,滤液减压浓缩得膏状物,放入烘箱烘干,烘箱干燥的温度为115℃,干燥时间18分钟,烘干后研磨成220目细粉,使其细粉量达到总料的95%以上,得所述药物。
实施例3 药物3
本发明实施例提供了一种用于治疗犬肺炎的药物,由以下重量份数的原料药材制成:党参26重量份、蕨萁18重量份、黄芪22重量份、火殃簕25重量份、百合19重量份、蛴螬17重量份、桔梗20重量份、匐地龙20重量份、薤白18重量份、款冬花27重量份、红麸杨20重量份、鞘菝葜18重量份、浙贝母28重量份、水茴香藻22重量份、杏仁25重量份、假蒟果穗25重量份、枇杷叶28重量份、白及27重量份、海螵蛸20重量份、麻黄26重量份、甘草22重量份、蕤仁20重量份、紫菀25重量份、白前25重量份、绵萆薢20重量份、鞘菝葜20重量份、矮地茶25重量份、胆南星28重量份、金沸草19重量份、射干20重量份、芜荑25重量份、牛蒡子20重量份、绒背蓟25重量份、山豆根27重量份和铺地黍19重量份。
上述药物是通过以下制备方法制得:将所有原料药材投入粉碎机中粉碎成细粉,放入耐酸碱浸渍锅,将相对于细粉质量的4倍的醇浓度为90%的乙醇倒入锅中,在常温常压下,浸渍28天,随后将浸渍好的液体及药渣压榨过滤,滤液减压浓缩得膏状物,放入烘箱烘干,烘箱干燥的温度为115℃,干燥时间20分钟,烘干后研磨成150目细粉,使其细粉量达到总料的95%以上,得所述药物。
毒性试验
1、蓄积毒性试验报告
选用30只健康小白鼠,雌、雄各10只,以本发明实施例1的药物为对象,剂量设计每7天为一期,每期剂量分别为0.10LD50 、0.20LD50 、0.25LD50 、0.30LD 50 、0.40LD50 ,此样品的雌性、雄性小鼠的LD 50均为4000m份/k份BW(五个剂量为500、750、1100、1800、2400m份/k份BW)。每7天称体重一次,调整给药量,按0.05ml/10份BW经口灌胃。28天后,动物无死亡情况发生,试验结束,按递增剂量给受试物28天后,雌性、雄性动物均无死亡情况发生。以实施例2、实施例3的药物为对象,按照上述方法进行毒性试验,结果如实施例1相同。
2、急性毒性试验
应用NIH小鼠40只,SPF级,雌雄各半,体重15~20g,进行急性毒性试验。小鼠随机分为两组,每组20只,即对照组和给药组,实验前禁食12小时;将本发明的实施例1制备的药物溶解在水中,(浓度为6.75g生药/ml,最高浓度)灌胃,灌胃容积为7ml/kg(即单次给药剂量为28.7生药/kg),对照组给予等量生理盐水,一天给药3次,给药间隔时间8小时,给药后连续观察14天,并记录小鼠的毒性反应及死亡数。实验结果表明:与对照组比较,给药后小鼠未见明显差异,实验连续观察21天,小鼠全身状况、饮食、饮水、体重增长均正常。因此本发明实施例1的药物的急性毒性低,临床用药安全。分别以实施例2和实施例3的药物为对象,按照上述方法进行毒性试验,结果如实施例1相同。
临床症状:
1、肺部听诊、病灶区、肺泡音减弱、可听到捻发音,在健康部位可听到声音。
2、血液变化、白细胞总数和嗜中性白细胞增多,并有核左移现象。X射检查,可见肺纹理增粗,并有片状阴影。
3、病初呈急性支气管炎症状,流鼻液、干性咳嗽、支气管音。随病情发展,全身情况恶化,精神沉郁,食欲减少或不食,体温升高39.54度,呈弛张热,呼吸困难,次数增加,结膜绀红,眼球下陷,脱水。
疗效诊断标准:
治愈:症状、体征、血常规检查均正常;
显效:症状、体征、血常规检查明显好转,但三项中有一项未完全恢复正常;
有效:用药后病情有所好转;
无效:用药后病情无明显好转或加重者。
治疗对比试验:
2010年5月-2012年5月,有400只患有肺炎的犬,将400只犬随机分成四组,分别为实施例组1、实施例组2、实施例组3和西药治疗组,分别使用实施例1制得的药物1、实施例2制得的药物2、实施例3制得的药物3进行治疗和传统药物进行治疗,其中,实施例组1-3的药量均为每只每日0.3g,治疗期间为10-20天;西药治疗组的传统药物选用四环素15mg/kg体重,地塞米松0.2mg/kg体重,溶于5%葡萄糖中,静脉注射,2次/日,治疗15-28天。治疗结束后观察三个月,记录各组狗的治愈率和死亡率,结果如表1所示。
治疗结果:
参见表1和表2,从表1可以看出,采用本发明的药物治疗犬肺炎,相对于西药在治疗效果上,具有显著的改进;从表2可以看出,采用本发明的药物治疗犬肺炎,相对于西药,在治疗疗程上显著缩短。
表1各实验组治疗效果对照表
表2 四组分别治疗4个疗程后治愈和显效头数和时间比较 例(%)
根据上述表格内的临床统计可知,本发明提供的药物具有治愈时间短、疗程短、疗效好,安全性高、针对性强等特点。
以上所述仅为本发明的较佳实施例,并不用以限制本发明,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (8)
1.一种用于治疗犬肺炎的药物,其特征在于,所述药物包括以下原料药材:党参、蕨萁、黄芪、火殃簕、百合、蛴螬、桔梗、匐地龙、薤白、款冬花、红麸杨、鞘菝葜、浙贝母、水茴香藻、杏仁、假蒟果穗、枇杷叶、白及、海螵蛸、麻黄、甘草、蕤仁、紫菀、白前、绵萆薢、鞘菝葜、矮地茶、胆南星、金沸草、射干、芜荑、牛蒡子、绒背蓟、山豆根和铺地黍。
2.根据权利要求1所述的用于治疗犬肺炎的药物,其特征在于,所述药物中各原料药材的重量份数为:党参10-30重量份、蕨萁15-30重量份、黄芪10-30重量份、火殃簕20-35重量份、百合10-30重量份、蛴螬15-35重量份、桔梗15-30重量份、匐地龙10-30重量份、薤白10-30重量份、款冬花20-35重量份、红麸杨10-30重量份、鞘菝葜10-30重量份、浙贝母15-30重量份、水茴香藻15-30重量份、杏仁15-35重量份、假蒟果穗15-30重量份、枇杷叶20-35重量份、白及10-30重量份、海螵蛸15-30重量份、麻黄20-35重量份、甘草10-30重量份、蕤仁15-30重量份、紫菀10-30重量份、白前15-30重量份、绵萆薢10-30重量份、鞘菝葜10-30重量份、矮地茶15-30重量份、胆南星15-30重量份、金沸草10-30重量份、射干10-30重量份、芜荑15-30重量份、牛蒡子10-30重量份、绒背蓟20-35重量份、山豆根15-35重量份和铺地黍10-30重量份。
3.根据权利要求1或2所述的用于治疗犬肺炎的药物,其特征在于,所述药物中各原料药材的重量份数为:党参15-30重量份、蕨萁15-25重量份、黄芪10-25重量份、火殃簕20-30重量份、百合15-30重量份、蛴螬15-30重量份、桔梗15-25重量份、匐地龙15-30重量份、薤白15-30重量份、款冬花25-35重量份、红麸杨15-30重量份、鞘菝葜15-30重量份、浙贝母20-30重量份、水茴香藻15-25重量份、杏仁15-30重量份、假蒟果穗20-30重量份、枇杷叶20-30重量份、白及15-30重量份、海螵蛸15-25重量份、麻黄20-30重量份、甘草15-30重量份、蕤仁15-25重量份、紫菀15-30重量份、白前20-30重量份、绵萆薢15-30重量份、鞘菝葜15-30重量份、矮地茶20-30重量份、胆南星20-30重量份、金沸草15-30重量份、射干15-30重量份、芜荑20-30重量份、牛蒡子15-30重量份、绒背蓟20-30重量份、山豆根15-30重量份和铺地黍15-30重量份。
4.根据权利要求1-3任一项所述的用于治疗犬肺炎的药物,其特征在于,所述药物中各原料药材的重量份数为:党参17-30重量份、蕨萁15-20重量份、黄芪15-25重量份、火殃簕22-30重量份、百合17-30重量份、蛴螬15-25重量份、桔梗17-25重量份、匐地龙18-25重量份、薤白15-25重量份、款冬花25-30重量份、红麸杨18-25重量份、鞘菝葜17-25重量份、浙贝母25-30重量份、水茴香藻19-25重量份、杏仁16-30重量份、假蒟果穗22-30重量份、枇杷叶22-30重量份、白及17-30重量份、海螵蛸18-25重量份、麻黄22-30重量份、甘草18-30重量份、蕤仁18-25重量份、紫菀19-30重量份、白前22-30重量份、绵萆薢17-30重量份、鞘菝葜18-30重量份、矮地茶22-30重量份、胆南星22-30重量份、金沸草16-30重量份、射干17-30重量份、芜荑22-30重量份、牛蒡子18-30重量份、绒背蓟22-30重量份、山豆根18-30重量份和铺地黍17-25重量份。
5.根据权利要求1-4任一项所述的用于治疗犬肺炎的药物,其特征在于,所述药物中各原料药材的重量份数为:党参17重量份、蕨萁15重量份、黄芪15重量份、火殃簕22重量份、百合17重量份、蛴螬15重量份、桔梗25重量份、匐地龙20重量份、薤白19重量份、款冬花25重量份、红麸杨22重量份、鞘菝葜25重量份、浙贝母27重量份、水茴香藻25重量份、杏仁18重量份、假蒟果穗25重量份、枇杷叶28重量份、白及18重量份、海螵蛸20重量份、麻黄25重量份、甘草22重量份、蕤仁20重量份、紫菀25重量份、白前25重量份、绵萆薢25重量份、鞘菝葜20重量份、矮地茶26重量份、胆南星25重量份、金沸草22重量份、射干19重量份、芜荑27重量份、牛蒡子28重量份、绒背蓟25重量份、山豆根27重量份和铺地黍22重量份。
6.根据权利要求1-5任一项所述的用于治疗犬肺炎的药物,其特征在于,所述药物中各原料药材的重量份数为:党参20重量份、蕨萁19重量份、黄芪20重量份、火殃簕25重量份、百合18重量份、蛴螬22重量份、桔梗20重量份、匐地龙20重量份、薤白19重量份、款冬花25重量份、红麸杨20重量份、鞘菝葜22重量份、浙贝母28重量份、水茴香藻20重量份、杏仁18重量份、假蒟果穗25重量份、枇杷叶27重量份、白及19重量份、海螵蛸22重量份、麻黄25重量份、甘草25重量份、蕤仁20重量份、紫菀20重量份、白前27重量份、绵萆薢18重量份、鞘菝葜25重量份、矮地茶27重量份、胆南星25重量份、金沸草18重量份、射干25重量份、芜荑22重量份、牛蒡子20重量份、绒背蓟25重量份、山豆根20重量份和铺地黍20重量份。
7.根据权利要求1-6任一项所述的用于治疗犬肺炎的药物,其特征在于,所述药物中各原料药材的重量份数为:党参26重量份、蕨萁18重量份、黄芪22重量份、火殃簕25重量份、百合19重量份、蛴螬17重量份、桔梗20重量份、匐地龙20重量份、薤白18重量份、款冬花27重量份、红麸杨20重量份、鞘菝葜18重量份、浙贝母28重量份、水茴香藻22重量份、杏仁25重量份、假蒟果穗25重量份、枇杷叶28重量份、白及27重量份、海螵蛸20重量份、麻黄26重量份、甘草22重量份、蕤仁20重量份、紫菀25重量份、白前25重量份、绵萆薢20重量份、鞘菝葜20重量份、矮地茶25重量份、胆南星28重量份、金沸草19重量份、射干20重量份、芜荑25重量份、牛蒡子20重量份、绒背蓟25重量份、山豆根27重量份和铺地黍19重量份。
8.根据权利要求1-7任一项所述的用于治疗犬肺炎的药物的制备方法,其特征在于,所述制备方法包括以下步骤:将所有原料药材投入粉碎机中粉碎成细粉,放入耐酸碱浸渍锅,将相对于细粉质量的3-5倍的醇浓度为80%-90%的乙醇倒入锅中,在常温常压下,浸渍20-30天,随后将浸渍好的液体及药渣压榨过滤,滤液减压浓缩得膏状物,放入烘箱烘干,烘箱干燥的温度为110-115℃,干燥时间10-20分钟,烘干后研磨成150-250目细粉,使其细粉量达到总料的95%以上,得所述药物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410199487.0A CN104001045A (zh) | 2014-05-13 | 2014-05-13 | 一种用于治疗犬肺炎的药物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410199487.0A CN104001045A (zh) | 2014-05-13 | 2014-05-13 | 一种用于治疗犬肺炎的药物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104001045A true CN104001045A (zh) | 2014-08-27 |
Family
ID=51362133
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410199487.0A Pending CN104001045A (zh) | 2014-05-13 | 2014-05-13 | 一种用于治疗犬肺炎的药物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104001045A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105079141A (zh) * | 2015-08-26 | 2015-11-25 | 中国农业科学院兰州畜牧与兽药研究所 | 一种治疗牦牛肺炎的藏兽药组合物及其制备方法和应用 |
CN105998970A (zh) * | 2016-06-02 | 2016-10-12 | 烟台民望机电技术有限公司 | 一种治疗犬传染性支气管炎的药物组合物及其制备方法 |
CN107174629A (zh) * | 2016-08-03 | 2017-09-19 | 李欣 | 慢性肺炎养肺缓咳中药剂 |
CN113068767A (zh) * | 2021-03-30 | 2021-07-06 | 中国热带农业科学院热带生物技术研究所 | 假蒟提取物在制备防治禽类曲霉菌病的添加剂中的应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103356888A (zh) * | 2013-07-11 | 2013-10-23 | 夏京奎 | 一种治疗小儿肺炎的中药颗粒 |
CN103656248A (zh) * | 2012-09-05 | 2014-03-26 | 张娅 | 一种治疗大叶性肺炎的中药组合物 |
-
2014
- 2014-05-13 CN CN201410199487.0A patent/CN104001045A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103656248A (zh) * | 2012-09-05 | 2014-03-26 | 张娅 | 一种治疗大叶性肺炎的中药组合物 |
CN103356888A (zh) * | 2013-07-11 | 2013-10-23 | 夏京奎 | 一种治疗小儿肺炎的中药颗粒 |
Non-Patent Citations (1)
Title |
---|
王文仕主编: "《伴侣动物养殖》", 31 January 2004, 四川科学技术出版社 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105079141A (zh) * | 2015-08-26 | 2015-11-25 | 中国农业科学院兰州畜牧与兽药研究所 | 一种治疗牦牛肺炎的藏兽药组合物及其制备方法和应用 |
CN105079141B (zh) * | 2015-08-26 | 2018-05-08 | 中国农业科学院兰州畜牧与兽药研究所 | 一种治疗牦牛肺炎的藏兽药组合物及其制备方法和应用 |
CN105998970A (zh) * | 2016-06-02 | 2016-10-12 | 烟台民望机电技术有限公司 | 一种治疗犬传染性支气管炎的药物组合物及其制备方法 |
CN107174629A (zh) * | 2016-08-03 | 2017-09-19 | 李欣 | 慢性肺炎养肺缓咳中药剂 |
CN113068767A (zh) * | 2021-03-30 | 2021-07-06 | 中国热带农业科学院热带生物技术研究所 | 假蒟提取物在制备防治禽类曲霉菌病的添加剂中的应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104187172B (zh) | 用于治疗乌龟肠胃炎病的功能性饲料及其制备方法 | |
CN104435944A (zh) | 一种治疗小儿咳嗽的中药组合物及其制备方法 | |
CN104367879A (zh) | 一种用于治疗鸡劳伤的药物组合物及其制备方法 | |
CN104873947A (zh) | 用于治疗狗急性上消化道出血的药物组合物及其制备方法 | |
CN103933425A (zh) | 一种治疗肺癌的中药组合物及其制备方法 | |
CN104001045A (zh) | 一种用于治疗犬肺炎的药物及其制备方法 | |
CN104069474A (zh) | 一种治疗脂溢性脱发的中药组合物及其制备方法 | |
CN104383288A (zh) | 一种用于治疗牛肺炎的药物组合物及其制备方法 | |
CN104147574A (zh) | 治疗感冒发烧的清热解表中药组合物及制备方法 | |
CN102327502A (zh) | 一种治疗气管炎的中药胶囊 | |
CN105055984A (zh) | 一种治疗哮喘的中药组合物及其制备方法 | |
CN104998197A (zh) | 一种用于治疗肝癌的中药组合物 | |
CN104352880A (zh) | 用于治疗狗细菌感染性感冒的药物组合物及其制备方法 | |
CN104189413A (zh) | 用于治疗乌龟肠胃炎病的药物组合物及其制备方法 | |
CN105435190A (zh) | 用于治疗寒热错杂型哮病的中药组合物及其制备方法 | |
CN104906502A (zh) | 一种用于治疗鸡伤热的药物组合物及其制备方法 | |
CN103830713B (zh) | 用于治疗鸡风寒型咳喘症的药物及其制备方法 | |
CN106109895A (zh) | 一种治疗肝郁痰火型慢性咽炎的中药组合物及方法 | |
CN106039075A (zh) | 一种治疗肺胃蕴热型慢性咽炎的中药组合物及方法 | |
CN105412643A (zh) | 一种治疗小儿水气凌心型哮喘的喷雾剂及其制备方法 | |
CN105267895A (zh) | 用于治疗牛产后血瘀型胞衣不下的药物及其制备方法 | |
CN105685745A (zh) | 一种具有消腻减肥之功效的醋饮及其制备方法 | |
CN105079425A (zh) | 一种治疗小儿手足口病的组合物制剂及其制备方法 | |
CN104707003B (zh) | 治疗高血压、高血脂的中药胶囊 | |
CN104491537A (zh) | 一种治疗风湿性心脏病的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140827 |
|
RJ01 | Rejection of invention patent application after publication |